Results 11 to 20 of about 1,308,546 (203)

Acute fulminant invasive pulmonary aspergillosis in an immunocompetent host: An autopsy case report

Medical Mycology Case Reports, 2018
A 62-year-old previously healthy male who was a welder/smoker/drinker was admitted to Kani Tono Hospital for severe hypoxemia (Day 0). Initial physical and radiological examinations suggested an acute exacerbation of chronic obstructive pulmonary disease.
Yuuki Ohara, Takahiko Ito, Makoto Ito, Kyoko Yamashita, Shinya Toyokuni   +4 more
doaj   +2 more sources

Invasive pulmonary aspergillosis [PDF]

Revista Clínica Española (English Edition), 2020
AbstractInvasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ transplantation, inherited or acquired immunodeficiency, administration of steroids or other immunosuppressive agents including monoclonal antibodies and new small ...
L A, Fernández-Bermejo, G, Ramírez-Olivencia   +1 more
  +11 more sources

Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hantavirus Infection, Austria

Emerging Infectious Diseases
We investigated a cohort of 370 patients in Austria with hantavirus infections (7.8% ICU admission rate) and detected 2 cases (cumulative incidence 7%) of invasive pulmonary aspergillosis; 1 patient died.
Stefan Hatzl, Laura Scholz, Florian Posch, Philipp Eller, Alexander C. Reisinger, Martin Zacharias, Gregor Gorkiewicz, Martin Hoenigl, Ines Zollner-Schwetz, Robert Krause   +9 more
doaj   +2 more sources

Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [PDF]

Current Medical Mycology, 2022
Background and Purpose: Influenza A and SARS-CoV-2 are risk factors for invasive pulmonary aspergillosis. Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical ...
Ahsan Syed, Kausar Jabeen, Joveria Farooqi, Hammad Niamatullah, Aisha Fareed Siddiqui, Safia Awan, Alishah Akbar, Irfan Muhammad   +7 more
doaj   +1 more source

Obstructive Tracheobronchitis in Influenza-Associated Pulmonary Aspergillosis

Diagnostics
We report a bronchoscopic image of a 36-year-old with significant airway obstruction from obstructive tracheobronchitis secondary to invasive pulmonary aspergillosis. It is rare to see such a severe form of obstructive tracheobronchitis, likely caused by
Shuyi Zhang, Chen Shang, Zhangjun Tan, Wen Li   +3 more
doaj   +2 more sources

Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™ [PDF]

, 2011
Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70–90%) in immunocompromised patients.
Italia, Jagdishbhai L, Kumar, M N V Ravi, Warn, Peter, Sharp, Andrew, Carter, Katharine C   +4 more
core   +5 more sources

Clinical periodontal diagnosis

Periodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi, Andrea Roccuzzo, Jean‐Claude Imber, Alexandra Stähli, Björn Klinge, Niklaus P. Lang   +5 more
wiley   +1 more source

Galactomannan-Antigen Testing from Non-Directed Bronchial Lavage for Rapid Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients: A Proof-of-Concept Study

Diagnostics, 2023
Invasive pulmonary aspergillosis is associated with high mortality. For diagnosis, galactomannan-antigen in serum and bronchoalveolar lavage fluid is recommended, with higher sensitivity in bronchoalveolar lavage fluid.
Kathrin Rothe, Miriam Dibos, Stefanie J. Haschka, Roland M. Schmid, Dirk Busch, Sebastian Rasch, Tobias Lahmer   +6 more
doaj   +1 more source

Invasive pulmonary aspergillosis

Expert Review of Anti-infective Therapy, 2005
In susceptible patients, invasive aspergillosis has a high incidence and a mortality of up to 80%. The diagnosis of this condition is difficult, especially in the early stages of the disease and, as a consequence, antifungal therapy, despite its expense and toxicity, is often initiated empirically.
S R, Doffman, S G, Agrawal, Jeremy S, Brown   +2 more
  +6 more sources

Successful treatment of invasive tracheobronchial pulmonary aspergillosis with venovenous extracorporeal membrane oxygenation and combined systemic, intratracheal instillation of liposomal amphotericin B: a case report

Journal of Medical Case Reports, 2022
Background Invasive pulmonary Aspergillus and invasive bronchial aspergillosis is a life-threatening opportunistic fungal infection that predominantly affects immunocompromised hosts.
Shuku Sato, Wataru Kamata, Kiyomitsu Fukaguchi, Shun Tsunoda, Tadashi Kamio, Hiroshi Koyama, Hideyasu Sugimoto, Yotaro Tamai   +7 more
doaj   +1 more source